Design and synthesis of isatin/triazole conjugates that induce apoptosis and inhibit migration of MGC-803 cells

European Journal of Medicinal Chemistry
2016.0

Abstract

A series of new isatin/triazole conjugates were designed based on the hypothesis that the ester-linked compounds could be enzymatically hydrolyzed by cellular esterases inside the cells. These compounds showed moderate to good growth inhibition toward the tested cancer cells, exerted selective inhibition toward MGC-803 cells and were less toxic to normal cells HL-7702 and GES-1. Of these compounds, compound 5a showed the best inhibitory activity against MGC-803 cells (IC50 = 9.78 μM), induced apoptosis through multiple mechanisms, as well as inhibited migration of MGC-803 cells.

Knowledge Graph

Similar Paper

Design and synthesis of isatin/triazole conjugates that induce apoptosis and inhibit migration of MGC-803 cells
European Journal of Medicinal Chemistry 2016.0
Azide-alkyne cycloaddition en route to novel 1H-1,2,3-triazole tethered isatin conjugates with in vitro cytotoxic evaluation
European Journal of Medicinal Chemistry 2012.0
Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety
European Journal of Medicinal Chemistry 2018.0
Discovery of 5,6-diaryl-1,2,4-triazines hybrids as potential apoptosis inducers
European Journal of Medicinal Chemistry 2017.0
Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents
European Journal of Medicinal Chemistry 2014.0
Synthesis of 1,2,4-triazole-linked urea/thiourea conjugates as cytotoxic and apoptosis inducing agents
Bioorganic & Medicinal Chemistry Letters 2018.0
Synthesis and apoptosis inducing studies of triazole linked 3-benzylidene isatin derivatives
European Journal of Medicinal Chemistry 2016.0
Synthesis and preliminary biological evaluation of 1,2,3-triazole-Jaspine B hybrids as potential cytotoxic agents
European Journal of Medicinal Chemistry 2014.0
Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents
European Journal of Medicinal Chemistry 2013.0
Design and synthesis of novel 1,2,3-triazole–pyrimidine–urea hybrids as potential anticancer agents
Bioorganic & Medicinal Chemistry Letters 2015.0